Reaction
Anal Inflammation reporting signals
As of the last recalculation, Anal Inflammation appears in 627 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is MESNA INJECTION (PRR 157.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Mesna Injection | 37 | 157.9 | 158.6 |
| Mesna | 37 | 155.0 | 155.7 |
| Trimethoprim | 36 | 107.5 | 107.8 |
| Ifosfamide | 42 | 69.5 | 69.6 |
| Piperacillin Sodium,Tazobactam Sodium | 47 | 63.5 | 63.6 |
| Docusate Sodium 100Mg | 39 | 57.7 | 57.8 |
| Cetirizine Hydrochloride Allergy | 38 | 44.3 | 44.3 |
| Cetirizine Hydrochloride Tablets | 38 | 44.3 | 44.3 |
| Pseudoephedrine Hydrochloride | 13 | 42.9 | 42.9 |
| Doxorubicin Hydrochloride | 38 | 41.1 | 41.1 |
| Pseudoephedrine Hcl | 13 | 40.0 | 40.0 |
| Meropenem | 32 | 34.8 | 34.9 |
| Pegaspargase | 11 | 30.3 | 30.4 |
| Infliximab-Dyyb | 22 | 25.9 | 25.9 |
| Venetoclax | 39 | 22.4 | 22.4 |
| Doxorubicin | 51 | 20.6 | 20.6 |
| Vedolizumab | 36 | 14.7 | 14.7 |
| Sunitinib Malate | 14 | 12.1 | 12.1 |
| Nirmatrelvir And Ritonavir | 7 | 4.3 | 4.3 |